Results 261 to 270 of about 13,428,920 (391)
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function [PDF]
G. Merlino+8 more
openalex +1 more source
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho+11 more
wiley +1 more source
Waves of Endurance: A Pilot Study of Beta Brain Wave Signatures Linked to Immune Adaptation in Transatlantic Rowers. [PDF]
Chandanathil M+9 more
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Time dynamics of elevated glucose and beta-hydroxybutyrate on beta cell mitochondrial metabolism. [PDF]
Hals I+8 more
europepmc +1 more source
Theoretical studies on the electrical activity of pancreatic beta-cells as a function of glucose
D.M. Himmel, Teresa Ree Chay
openalex +1 more source
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
BSD: A Bayesian Framework for Parametric Models of Neural Spectra. [PDF]
Medrano J+3 more
europepmc +1 more source
Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients [PDF]
J C Pujet+4 more
openalex +1 more source
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach+8 more
wiley +1 more source